Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ADOPTIVE IMMUNOTHERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 691 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chiorean, EG; Miller, JS
      The biology of natural killer cells and implications for therapy of human disease

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Porter, DL
      The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    3. Sen, M; Wankowski, DM; Garlie, NK; Siebenlist, RE; Van Epps, D; LeFever, AV; Lum, LG
      Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumors

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    4. Tanigawa, K; Takeshita, N; Eickhoff, GA; Shimizu, K; Chang, AE
      Antitumor reactivity of lymph node cells primed in vivo with dendritic cell-based vaccines

      JOURNAL OF IMMUNOTHERAPY
    5. Rousseau, RF; Bollard, CM; Heslop, HE
      Gene therapy for paediatric leukaemia

      EXPERT OPINION ON BIOLOGICAL THERAPY
    6. Nawrocki, S; Wysocki, PJ; Mackiewicz, A
      Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer

      EXPERT OPINION ON BIOLOGICAL THERAPY
    7. Bhatia, V; Porter, DL
      Novel approaches to allogeneic stem cell therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    8. Coze, C; Leimig, T; Jimeno, MT; Mannoni, P
      Retrovirus-mediated gene transfer of the cytokine genes interleukin-1 betaand tumor necrosis factor-alpha into human neuroblastoma cells: consequences for cell line behavior and immunomodulatory properties

      EUROPEAN CYTOKINE NETWORK
    9. Porter, DL; Luger, SM; Duffy, KM; Stadtmauer, EA; Laport, G; Schuster, SJ; Orloff, G; Tsai, D; McDaid, K; Kathakali, A; Leonard, DGB; Antin, JH
      Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    10. Dey, BR; McAfee, S; Sackstein, R; Colby, C; Saidman, S; Weymouth, D; Poliquin, C; Vanderklish, J; Sachs, DH; Sykes, M; Spitzer, TR
      Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    11. Shimoni, A; Gajewski, J; Donato, M; Martin, T; O'Brien, S; Talpaz, M; Cohen, A; Korbling, M; Champlin, R; Giralt, S
      Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    12. Carlens, S; Remberger, M; Aschan, J; Ringden, O
      The role of disease stage in the response to donor lymphocyte infusions astreatment for leukemic relapse

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    13. Clemons-Miller, AR; Chatta, GS; Hutchins, L; Angtuaco, EJ; Ravaggi, A; Santin, AD; Cannon, MJ
      Intrathecal cytotoxic T-cell immunotherapy for metastatic leptomeningeal melanoma

      CLINICAL CANCER RESEARCH
    14. Feinstein, L; Storb, R
      Reducing transplant toxicity

      CURRENT OPINION IN HEMATOLOGY
    15. Peggs, KS; Mackinnon, S
      Cellular therapy: donor lymphocyte infusion

      CURRENT OPINION IN HEMATOLOGY
    16. Khurana, D; Martin, EA; Kasperbauer, JL; O'Malley, BW; Salomao, DR; Chen, LP; Strome, SE
      Characterization of a spontaneously arising murine squamous cell carcinoma(SCC VII) as a prerequisite for head and neck cancer immunotherapy

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    17. Wittig, B; Marten, A; Dorbic, T; Weineck, S; Min, H; Niemitz, S; Trojaneck, B; Flieger, D; Kruopis, S; Albers, A; Loffel, J; Neubauer, A; Albers, P; Muller, S; Sauerbruch, T; Bieber, T; Huhn, D; Schmidt-Wolf, IGH
      Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: A first clinical phase I/II trial

      HUMAN GENE THERAPY
    18. Finberg, RW
      Epstein-Barr virus-specific T cells for the management of Epstein-Barr virus lymphomas

      CURRENT OPINION IN ONCOLOGY
    19. Czerniecki, BJ; Cohen, PA; Faries, M; Xu, SW; Roros, JG; Bedrosian, I
      Diverse functional activity of CD83(+) monocyte-derived dendritic cells and the implications for cancer vaccines

      CRITICAL REVIEWS IN IMMUNOLOGY
    20. Akagi, J; Takai, E; Tamori, Y; Ogawa, M
      CD3(+)CD56(+)CD8(+) cells demonstrating a suppressor T cell-like function in the peripheral blood of colon cancer patients

      INTERNATIONAL JOURNAL OF ONCOLOGY
    21. Chen, J; Niu, HT; He, W; Ba, DN
      Antitumour activity of expanded human tumor-infiltrating gamma delta T lymphocytes

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    22. Hombach, A; Muche, JM; Gerken, M; Gellrich, S; Heuser, C; Pohl, C; Sterry, W; Abken, H
      T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells

      GENE THERAPY
    23. Rosenberg, SA
      Progress in the development of immunotherapy for the treatment of patientswith cancer

      JOURNAL OF INTERNAL MEDICINE
    24. Hilbert, U; Jelinek, N; Schmidt, S; Biselli, M
      Bioprocess development for the cultivation of human T-lymphocytes

      CHEMICAL ENGINEERING & TECHNOLOGY
    25. Vindelov, L
      Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

      EUROPEAN JOURNAL OF HAEMATOLOGY
    26. Schaap, N; Schattenberg, A; Bar, B; Preijers, F; van Kemenade, EV; de Witte, T
      Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donorleukocyte infusions

      LEUKEMIA
    27. Keil, F; Prinz, F; Kalhs, P; Lechner, K; Moser, K; Schwarzinger, I; Jager, U; Fonatsch, C; Worel, N; Mannhalter, C; Rabitsch, W; Loidolt, H; Schulenburg, A; Mitterbauer, M; Hocker, P; Greinix, HT
      Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

      LEUKEMIA
    28. Sosman, JA; Stiff, P; Moss, SM; Sorokin, P; Martone, B; Bayer, R; van Besien, K; Devine, S; Stock, W; Peace, D; Chen, Y; Long, C; Gustin, D; Viana, M; Hoffman, R
      Pilot trial of interleukin-1 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: Expansion of immune effectors within the stem-cell graft and post-stem-cell infusion

      JOURNAL OF CLINICAL ONCOLOGY
    29. Phan, GQ; Attia, P; Steinberg, SM; White, DE; Rosenberg, SA
      Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    30. Vonderheide, RH; Dutcher, JP; Anderson, JE; Eckhardt, SG; Stephans, KF; Razvillas, B; Garl, S; Butine, MD; Perry, VP; Armitage, RJ; Ghalie, R; Caron, DA; Gribben, JG
      Phase I study of recombinant human CD40 ligand in cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    31. Baron, F; Frere, P; Fillet, G; Beguin, Y
      Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571

      HAEMATOLOGICA
    32. Quillien, V; Moisan, A; Lesimple, T; Leberre, C; Toujas, L
      Biodistribution of (111)indium-labeled macrophages infused intravenously in patients with renal carcinoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    33. Kobayashi, H; Tanaka, Y; Yagi, J; Toma, H; Uchiyama, T
      Gamma/delta T cells provide innate immunity against renal cell carcinoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    34. Check, JH; Nazari, P; Goldberg, J; Yuen, W; Angotti, D
      A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion

      MEDICAL HYPOTHESES
    35. Koelemij, R; Hagenaars, M; Ensink, NG; Eggermont, AMM; Van De Velde, CJH; Fleuren, GJ; Kuppen, PJK
      Administration of BiMAb-retargeted T cells in a rat hepatic metastases colon tumour model results in T-cell tumour infiltration independent of the route of administration

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    36. Ferra, C; Rodriguez-Luaces, M; Gallardo, D; Encuentra, M; Martin-Henao, GA; Peris, J; Ancin, I; Serra, J; Berlangal, JJ; Garcia, J; Granena, A
      Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    37. Yamaguchi, Y; Ohta, K; Shimizu, K; Minami, K; Noma, K; Hihara, J; Toge, T
      Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2

      ANTICANCER RESEARCH
    38. Carlens, S; Gilljam, M; Chambers, BJ; Aschan, J; Guven, H; Ljunggren, HG; Christensson, B; Dilber, MS
      A new method for in vitro expansion of cytotoxic human CD3(-)CD56(+) natural killer cells

      HUMAN IMMUNOLOGY
    39. Seeley, BM; Barthel, SW; To, WC; Kjaergaard, J; Shu, S; Plautz, GE
      Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 costimulation

      OTOLARYNGOLOGY-HEAD AND NECK SURGERY
    40. Wroblewski, JM; Bixby, DL; Borowski, C; Yannelli, JR
      Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens

      LUNG CANCER
    41. Lee, JH; Lee, KH; Kim, S; Seol, M; Kim, SH; Kim, WK; Lee, JS
      Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plusetoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation

      LEUKEMIA RESEARCH
    42. Mieijer, SL; Dols, A; Hu, HM; Jensen, S; Poehlein, CH; Chu, Y; Winter, H; Yamada, J; Moudgil, T; Wood, WJ; Doran, T; Justice, L; Fisher, B; Wisner, P; Wood, J; Vetto, JT; Mehrotra, R; Rosenheim, S; Weinberg, AD; Bright, R; Walker, E; Puri, R; Smith, JW; Urba, WJ; Fox, BA
      Immunological and molecular analysis of the sentinel lymph node: A potential approach to predict outcome, tailor therapy, and optimize parameters fortumor vaccine development

      JOURNAL OF CLINICAL PHARMACOLOGY
    43. Snyder, EL; O'Donnell, L; Dengler, TJ; Pomper, GJ; Velleca, MA; Dincecco, DM; Baril, LL; Min, K; Gudino, MD; Bender, JR
      Ex vivo evaluation of PBMNCs collected with a new cell separator

      TRANSFUSION
    44. Bensinger, WI; Maloney, D; Storb, R
      Allogeneic hematopoietic cell transplantation for multiple myeloma

      SEMINARS IN HEMATOLOGY
    45. Garlie, NK; Siebenlist, RE; Lefever, AV
      T cells activated in vitro as immunotherapy for renal, cell carcinoma: Characterization of 2 effector T-cell populations

      JOURNAL OF UROLOGY
    46. Chin, CS; Graham, LJ; Hamad, GG; George, KR; Bear, HD
      Bryostatin/ionomycin-activated T cells mediate regression of established tumors

      JOURNAL OF SURGICAL RESEARCH
    47. Tanigawa, K; Takeshita, N; Craig, RA; Phillips, K; Knibbs, RN; Chang, AE; Stoolman, LM
      Tumor-specific responses in lymph nodes draining murine sarcomas are concentrated in cells expressing P-selectin binding sites

      JOURNAL OF IMMUNOLOGY
    48. Bergmann, CC; Ramakrishna, C; Kornacki, M; Stohlman, SA
      Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection

      JOURNAL OF IMMUNOLOGY
    49. Keogh, E; Fikes, J; Southwood, S; Celis, E; Chesnut, R; Sette, A
      Identification of new epitopes from four different tumor-associated antigens: Recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity

      JOURNAL OF IMMUNOLOGY
    50. Kemp, RA; Ronchese, F
      Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity

      JOURNAL OF IMMUNOLOGY
    51. Fujita, N; Kagamu, H; Yoshizawa, H; Itoh, K; Kuriyama, H; Matsumoto, N; Ishiguro, T; Tanaka, J; Suzuki, E; Hamada, H; Gejyo, F
      CD40 ligand promotes priming of fully potent antitumor CD4(+) T cells in draining lymph nodes in the presence of apoptotic tumor cells

      JOURNAL OF IMMUNOLOGY
    52. Carta, L; Pastorino, S; Melillo, G; Bosco, MC; Massazza, S; Varesio, L
      Engineering of macrophages to produce IFN-gamma in response to hypoxia

      JOURNAL OF IMMUNOLOGY
    53. Pelaez, B; Campillo, JA; Lopez-Asenjo, JA; Subiza, JL
      Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism

      JOURNAL OF IMMUNOLOGY
    54. Fonteneau, JF; Larsson, M; Somersan, S; Sanders, C; Munz, C; Kwok, WW; Bhardwaj, N; Jotereau, F
      Generation of high quantities of viral and tumor-specific human CD4+and CD8+T-cell clones using peptide pulsed mature dendritic cells

      JOURNAL OF IMMUNOLOGICAL METHODS
    55. Saleh, FH; Crotty, KA; Hersey, P; Menzies, SW
      Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen Melan-A/MART-1

      INTERNATIONAL JOURNAL OF CANCER
    56. Rossig, C; Bollard, CM; Nuchtern, JG; Merchant, DA; Brenner, MK
      Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes

      INTERNATIONAL JOURNAL OF CANCER
    57. Chen, Z; Moyana, T; Saxena, A; Warrington, R; Jia, ZC; Xiang, J
      Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells

      INTERNATIONAL JOURNAL OF CANCER
    58. Korbelik, M; Sun, J
      Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line

      INTERNATIONAL JOURNAL OF CANCER
    59. Ansari, AA; Bostik, P; Mayne, AE; Villinger, F
      Failure to expand influenza and tetanus toxoid memory T cells in vitro correlates with disease course in SIV infected rhesus macaques

      CELLULAR IMMUNOLOGY
    60. Meij, P; Bloemena, E; Palmen, N; Brink, A; Vervoort, MBHJ; Meijer, CJLM; Middeldorp, JN
      Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines

      CELLULAR IMMUNOLOGY
    61. Kim, JA; Averbook, BJ; Chambers, K; Rothchild, K; Kjaergaard, J; Papay, R; Shu, SY
      Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation

      CANCER RESEARCH
    62. Eastman, ME; Khorsand, M; Maki, DG; Williams, EC; Kim, K; Sondel, PM; Schiller, JH; Albertini, MR
      Central venous device-related infection and thrombosis in patients treatedwith moderate dose continuous-infusion interleukin-2

      CANCER
    63. Brouwer, RE; Hoefnagel, J; van der Burg, BB; Jedema, I; Zwinderman, KH; Starrenburg, ICW; Kluin-Nelemans, HC; Barge, RMY; Willemze, R; Falkenburg, JHF
      Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis

      BRITISH JOURNAL OF HAEMATOLOGY
    64. Rodella, L; Zamai, L; Rezzani, R; Artico, M; Peri, G; Falconi, M; Facchini, A; Pelusi, G; Vitale, M
      Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells

      BRITISH JOURNAL OF HAEMATOLOGY
    65. Kleihauer, A; Grigoleit, U; Hebart, H; Moris, A; Brossart, P; Muhm, A; Stevanovic, S; Rammensee, HG; Sinzger, C; Riegler, S; Jahn, G; Kanz, L; Einsele, H
      Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells

      BRITISH JOURNAL OF HAEMATOLOGY
    66. Morton, J; Hutchins, C; Durrant, S
      Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells

      BLOOD
    67. Harrison, BD; Adams, JA; Briggs, M; Brereton, ML; Yin, JAL
      Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia

      BLOOD
    68. Thall, PF; Sung, HG; Choudhury, A
      Dose-finding based on feasibility and toxicity in T-cell infusion trials

      BIOMETRICS
    69. Lum, LG; Sen, M
      Activated T-cell and bispecific antibody immunotherapy for high-risk breast cancer - Bench to bedside

      ACTA HAEMATOLOGICA
    70. Barta, A; Denes, R; Masszi, T; Remenyi, P; Batai, A; Torbagyi, E; Sipos, A; Lengyel, L; Jakab, K; Gyodi, E; Reti, M; Foldi, J; Paldi-Haris, P; Avalos, M; Paloczi, K; Fekete, S; Torok, J; Hoffer, I; Jakab, J; Varadi, G; Kelemen, E; Petranyi, G
      Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia

      ACTA HAEMATOLOGICA
    71. Steiner, T; Schubert, J
      Systemic treatment of renal-cell carcinoma: present status

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    72. Dudley, ME; Ngo, LT; Westwood, J; Wunderlich, JR; Rosenberg, SA
      T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes

      CANCER JOURNAL
    73. Carswell, KS; Papoutsakis, ET
      Extracellular pH affects the proliferation of cultured human T cells and their expression of the interleukin-2 receptor

      JOURNAL OF IMMUNOTHERAPY
    74. Lesimple, T; Moisan, A; Guille, F; Leberre, C; Audran, R; Drenou, B; Toujas, L
      Treatment of metastatic renal cell carcinoma with activated autologous macrophages and granulocyte-macrophage colony-stimulating factor

      JOURNAL OF IMMUNOTHERAPY
    75. Tanigawa, K; Craig, RA; Stoolman, LM; Chang, AE
      Effects of tumor necrosis factor-alpha on the in vitro maturation of tumor-reactive effector T cells

      JOURNAL OF IMMUNOTHERAPY
    76. Frohn, C; Doehn, C; Durek, C; Bohle, A; Schlenke, P; Jocham, D; Kirchner, H
      Feasibility of the adoptive transfusion of allogenic human leukocyte antigen-matched natural killer cells in patients with renal cell carcinoma

      JOURNAL OF IMMUNOTHERAPY
    77. Beecham, EJ; Ortiz-Pujols, S; Junghans, RP
      Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor

      JOURNAL OF IMMUNOTHERAPY
    78. Aruga, E; Tanigawa, K; Aruga, A; Arai, H; Smith, JW; Nickoloff, BJ; Nabel, GJ; Chang, AE
      CD95-mediated tumor recognition by CD4(+) effector cells in a murine mammary model

      JOURNAL OF IMMUNOTHERAPY
    79. Contreras, TN; Krammer, PH; Potkul, PK; Bu, P; Rossi, JL; Kaufmann, AM; Gissmann, G; Qiao, LA
      Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes

      JOURNAL OF IMMUNOTHERAPY
    80. Wiers, KM; Lathers, DMR; Wright, MA; Young, MRI
      Vitamin D-3 treatment to diminish the levels of immune suppressive CD34(+)cells increases the effectiveness of adoptive immunotherapy

      JOURNAL OF IMMUNOTHERAPY
    81. Ratto, GB; Cafferata, MA; Scolaro, G; Bruzzi, P; Alloisio, A; Costa, R; Spessa, E; Semino, C; Melioli, G
      Phase II study of combined immunotherapy, chemotherapy, and radiotherapy in the postoperative treatment of advanced non-small-cell lung cancer

      JOURNAL OF IMMUNOTHERAPY
    82. Li, Q; Normolle, DP; Sayre, DM; Zeng, XY; Sun, R; Jiang, GH; Redman, B; Chang, AE
      Immunological effects of BCG as an adjuvant in autologous tumor vaccines

      CLINICAL IMMUNOLOGY
    83. Tjoa, BA; Salgaller, ML
      Progress in active-specific immunotherapy of brain malignancies

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    84. Bouet-Toussaint, F; Genetet, N; Rioux-Leclercq, N; Bansard, JY; Leveque, J; Guille, F; Patard, JJ; Lesimple, T; Catros-Quemener, V
      Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer

      EUROPEAN CYTOKINE NETWORK
    85. Latouche, JB; Sadelain, M
      Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells

      NATURE BIOTECHNOLOGY
    86. Trojaneck, B; Niemitz, S; Micka, B; Lefterova, P; Blasczyk, R; Scheffold, C; Huhn, D; Schmidt-Wolf, IGH
      Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    87. Flowers, MED; Leisenring, W; Beach, K; Riddell, S; Radich, JP; Higano, CS; Rowley, SD; Chauncey, TR; Bensinger, WI; Sanders, JE; Anasetti, C; Storb, R; Wade, J; Appelbaum, FR; Martin, PJ
      Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion forrecurrent chronic myeloid leukemia after bone marrow transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    88. Kilbourn, RG; Fonseca, GA; Trissel, LA; Griffith, OW
      Strategies to reduce side effects of interleukin-2: Evaluation of the antihypotensive agent N-G-monomethyl-L-arginine

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    89. Freedman, RS; Kudelka, AP; Kavanagh, JJ; Verschraegen, C; Edwards, CL; Nash, M; Levy, L; Atkinson, EN; Zhang, HZ; Melichar, B; Patenia, R; Templin, S; Scott, W; Platsoucas, CD
      Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma

      CLINICAL CANCER RESEARCH
    90. Toh, U; Yamana, H; Sueyoshi, S; Tanaka, T; Niiya, F; Katagiri, K; Fujita, H; Shirozou, K; Itoh, K
      Locoregional cellular immunotherapy for patients with advanced esophageal cancer

      CLINICAL CANCER RESEARCH
    91. Chang, AE; Li, Q; Bishop, DK; Normolle, DP; Redman, BD; Nickoloff, BJ
      Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor

      HUMAN GENE THERAPY
    92. Ren-Heidenreich, L; Hayman, GT; Trevor, KT
      Specific targeting of EGP-2(+) tumor cells by primary lymphocytes modifiedwith chimeric T cell receptors

      HUMAN GENE THERAPY
    93. Araki, K; Noguchi, Y; Hirouchi, T; Yoshikawa, E; Kataoka, S; Silverni, L; Miyazawa, H; Kuzuhara, H; Suzuki, C; Shimada, Y; Hamasato, S; Maeda, N; Shimamura, Y; Ogawa, Y; Ohtsuki, Y; Fujimoto, S
      Cancer regression induced by modified CTL therapy is regulated by HLA class II and class I antigens in Japanese patients with advanced cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    94. Hiller, C; Wittmann, S; Slavin, S; Fickenscher, H
      Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector

      GENE THERAPY
    95. Lei, H; Ju, DW; Yu, Y; Tao, Q; Chen, G; Gu, S; Hamada, H; Cao, X
      Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factorand interferon-gamma

      GENE THERAPY
    96. Thomsen, AR; Nansen, A; Andreasen, SO; Wodarz, D; Christensen, JP
      Host factors influencing viral persistence

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    97. Di Ianni, M; Di Florio, S; Venditti, G; Liberatore, C; Lucheroni, F; Falzetti, F; Terenzi, A; Stella, CC; Spinozzi, F; Mannoni, P; Martelli, MF; Tabilio, A
      T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection

      CANCER GENE THERAPY
    98. Saijo, K; Tsurushima, H; Tsuboi, K; Nose, T; Oki, A; Ohno, T
      Recycled addition of CD4(+) T cell-rich population for induction of human autologous cytotoxic T lymphocytes: A practically efficient method

      CYTOTECHNOLOGY
    99. Talpaz, M; Berman, E; Clift, RA; Copelan, EA; Emanuel, PD; Erba, HP; Glenn, MJ; Greenberg, PL; Jones, RJ; O'Brien, S; Saba, HI; Schilder, R; Snyder, DS; Soiffer, RJ; Tallman, MS; Wetzler, M; Ravandi-Kashani, F; Kantarjian, H; Talpaz, M
      NCCN Practice Guidelines for chronic myelogenous leukemia

      ONCOLOGY-NEW YORK
    100. Shimizu, N; Sekine, T; Itoh, K; Nakamura, T; Iwamoto, A; Satoh, Y; Yamamoto, K
      Large-scale ex vivo expansion of primary T lymphocytes in late-stage AIDS patients

      AIDS RESEARCH AND HUMAN RETROVIRUSES


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 22:36:34